The AI discovery platform for longevity.
LEVL maps the biology of aging to discover synergistic formulations and personalized protocols that help people live healthier, longer.
Reads and structures scientific literature
Scores compounds and synergistic combinations
Connects mechanisms to hallmarks of aging
Learns from real-world biomarker outcomes
We are building the intelligence layer for the next generation of longevity products.
Aging is a systems problem.
For decades, longevity science has been trapped in fragments.
One paper on autophagy.
One study on mitochondrial function.
One supplement for sleep.
One biomarker panel every few months.
One protocol built from expert intuition.
But aging does not happen one pathway at a time.
It emerges from interacting biological systems: impaired autophagy, mitochondrial dysfunction, deregulated nutrient sensing, chronic inflammation, cellular senescence, genomic instability, epigenetic drift, and other hallmarks of aging.
LEVL was built for that complexity.
Our platform organizes longevity science into a living map of compounds, pathways, hallmarks, functional outcomes, biomarkers, doses, and real-world results, then uses that map to discover combinations that single-ingredient thinking misses.
The LEVL Platform
Discovery becomes product. Product becomes data. Data improves discovery.
Literature Engine
Reads and structures longevity research from scientific papers.
Longevity Graph
Maps compounds, pathways, hallmarks of aging, biomarkers, and functional outcomes into a cohesive biological network.
Synergy Engine
Ranks combinations by mechanism, evidence strength, dose feasibility, safety, and expected biological effect.
Protocol App
Turns discoveries into personalized interventions users can follow, measure, and improve.
Feedback Loop
Learns from biomarkers, subjective outcomes, adherence, and real-world protocol results.
LEV Benchmark
The validation layer for the platform. When users execute platform-recommended protocols in the LEVL App, their real-world outcomes are submitted to the LEV Benchmark (powered by LongevityReviews.org). This creates a public, outcome-driven scoreboard that ranks protocol-generating AIs and their specific recommendations against objective Pace of Aging (PoA) improvements in real people.
LEV Trajectory
Projections driven by validated benchmarks. The velocity improvements proven on the LEV Benchmark directly feed your LEV Trajectory projection. This models your personal escape velocity—the threshold where biological rate of aging is slowed enough that life expectancy gains outpace chronological time. The benchmark validates the speed; the trajectory maps the horizon.
Interactive LEV Trajectory ToolPace of Aging
Static biological age clocks only show a snapshot of the past. The true indicator of longevity intervention success is the Pace of Aging (PoA)—the speed at which your biology is changing relative to chronological time.
Recent breakthroughs in epigenetic methylation testing (such as the DunedinPACE algorithm developed at Duke and Otago University) have made it possible to measure this rate of biological decay with high precision. By slowing down this "speedometer", we directly delay the onset of age-related decline.
Why It Matters
A clinical study or personal protocol that reduces chronological speed of aging (e.g., from 1.0 to 0.8 biological years per chronological year) represents a compounding systemic delay in disease vulnerability.
LEVL Pace of Aging Algorithm
Rather than requiring complex, high-cost epigenetic clocks from day one, LEVL builds a modular model that productizes open-source aging research, making benchmarking accessible with whatever data you have.
Competes & aggregates across multiple biological age models
This algorithm forms the benchmarking backend for LEVL's protocol optimization engine. Over time, user results guide protocol suggestions, allowing models to output actions in a shared format and iteratively improve formulations.
Longevity is becoming computable.
For the first time, the pieces exist for a true longevity discovery platform.
Scientific literature can be read and structured by AI.
The hallmarks of aging give the field a shared biological framework.
Consumer biomarker testing is becoming mainstream.
Wearables and apps make daily health feedback measurable.
AI can compare thousands of mechanisms, compounds, and outcomes at a scale no human team can hold in memory.
The bottleneck is no longer whether the science exists.
The bottleneck is whether we can organize it, score it, test it, and personalize it fast enough.
That is what LEVL is building.
How It Works
From aging science to personalized protocols.
Ingest
LEVL ingests scientific papers, pathway databases, hallmark-of-aging research, compound data, biomarker evidence, and real-world protocol outcomes.
The platform is designed to pull longevity science out of static documents and into a structured discovery system.
GET /api/ingest/literature?source=pubmed
Success: 24,105 documents queued
Processing text extraction...
Identifying mechanistic entities...
Linking to hallmark ontology...
_
Continuously ingesting and structuring from
Structure
The platform extracts the useful signal, answering precise biological questions. This turns scattered papers into searchable biological intelligence.
{
"entity": "Fisetin",
"type": "flavonoid",
"mechanisms": [
{
"pathway": "mTORC1",
"effect": "inhibition",
"hallmark": "Nutrient Sensing"
},
{
"pathway": "senolysis",
"effect": "activation",
"hallmark": "Cellular Senescence"
}
],
"confidence_score": 0.94
}Score
Every compound and combination can be ranked across dimensions that matter:
Hallmark impact
Directly targeting biological drivers of aging.
Functional benefit
Outcomes like energy, sleep, cognition, and recovery.
Pathway activation
Which mechanisms are affected, and how strongly?
Synergy Score Output
Formulate
LEVL uses this ranked evidence to identify high-potential combinations for LIFESPAN+, our line of science-driven formulations designed to support the biological foundations of healthy aging.
We do not start with trend ingredients.
We start with the biology.
Personalize
The same platform that powers formulation discovery also informs personalized protocols.
A user’s goals, biomarkers, wearable data, qualitative feedback, and adherence patterns can help determine which interventions are most relevant for their biology.
Learn
Real-world outcomes feed back into the platform.
If a protocol successfully reduces your Pace of Aging (PoA) methylation rate or blood-based biological age index, that is the ultimate signal of success.
If a protocol improves sleep quality, energy, recovery, glucose stability, inflammatory markers, or other health signals, that matters.
If an intervention looks strong in the literature but fails to translate in practice, that matters too.
LEVL is designed to become smarter with every validated signal.
Built for scientific accountability.
Longevity has too much hype and too little infrastructure. LEVL is building the opposite: an auditable system for translating longevity science into products and protocols.
Source-linked
Claims trace back to supporting literature.
Mechanism-mapped
Ingredients connect to pathways, biomarkers, and hallmarks of aging.
Evidence-weighted
Human evidence counts more than animal evidence. Animal evidence counts more than cell data. Weak evidence is not treated like strong evidence.
Dose-aware
Promising mechanisms are filtered through practical, safe, human-relevant dose ranges.
Outcome-updated
Real-world feedback helps refine future scoring and protocol recommendations.
The goal is not to replace scientific judgment.
The goal is to give scientists, clinicians, partners, and customers a better map.
Targeting the hallmarks of aging.
The hallmarks of aging are the biological drivers that shape how our bodies decline over time. LEVL uses them as a core framework for discovery.
Instead of asking whether an ingredient is “good for longevity” in the abstract, our platform asks more precise questions:
Does it support autophagy and cellular clearance?
Does it improve mitochondrial resilience and energy production?
Does it target senescent cell burden and chronic inflammation?
Does it translate into measurable real-world functional benefits?
This is how longevity becomes actionable.
Not vague anti-aging.
Mechanism by mechanism.
Pathway by pathway.
Protocol by protocol.
DeepCell
Optimized for deep sleep and longevity.
DeepCell is LEVL’s first platform-discovered formulation. Over 9 distinct iterations, our platform read scientific literature, scored synergistic compound combinations, and connected mechanisms to the hallmarks of aging to optimize this specific protocol.
The result is a highly refined daily formulation that supports both restorative deep sleep and fasting-associated cellular renewal, continuously improved by learning from real-world biomarker and protocol outcomes.
LIFESPAN+ is the first commercial expression of the LEVL platform.
LEVL’s discovery engine powers the development of LIFESPAN+, our line of formulations designed to support the foundations of healthy aging. Each product begins with a biological question:
"What combination of naturally derived compounds can safely support the systems that help people feel, function, and age better?"
From there, LEVL evaluates mechanisms, evidence strength, hallmark coverage, dosing, safety, synergy, and real-world outcomes.
The result is not another supplement stack. It is a new model for building longevity products: computationally discovered, biologically mapped, and continuously improved.
LIFESPAN+ Activate
Targeted autophagy and cellular clearance.
The first patent from the LEVL platform is a synergistic combination of 3 ingredients that combined induces comparable levels of autophagy as Rapamycin without the negative immune suppressing side effects.
It is a powerful fasting mimetic that activates the same longevity enhancing pathways without the need for caloric restriction.
Built for the longevity ecosystem.
LEVL is not just building products. We are building infrastructure for the next generation of personalized longevity.
For biomarker companies
LEVL can help turn test results into personalized, evidence-linked protocols.
For clinics and practitioners
LEVL can support protocol design, adherence tracking, and longitudinal outcome monitoring.
For researchers
LEVL provides a structured way to explore compounds, pathways, hallmarks, mechanisms, and synergistic combinations.
For formulation partners
LEVL shortens the path from biological hypothesis to testable product candidate.
For customers
LEVL translates complex aging science into daily protocols people can actually follow.
A platform company with a product wedge.
The first wave of consumer longevity was content, coaching, and generic supplements. The next wave will be adaptive, evidence-linked, and personalized.
LEVL is building toward that future from both sides: A commercial product engine through LIFESPAN+ formulations, and a data intelligence engine through the LEVL Protocols App and Synergy Platform.
Better science creates better products.
Better products create more users.
More users create more outcome data.
More outcome data improves the platform.
A better platform creates better products.
This is how LEVL moves from supplement company to longevity infrastructure company.
Our mission is Longevity Escape Velocity.
LEVL exists to help humanity reach a future where healthy lifespan increases faster than chronological time passes.
That future will not come from generic wellness advice. It will come from systems that can discover better interventions, personalize them to individual biology, measure whether they work, and improve continuously.
Tomorrow, it means a world where age-related decline is no longer accepted as inevitable.